MedTrace Logo

Clinical Trial in China for Aortic Valve Stenosis

NCT05607667 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-07-28

No results posted yet for this study

Summary

The purpose of this clinical study is to evaluate the effectiveness and safety of the transcatheter aortic valve system in the treatment of patients with severe aortic stenosis disease who are at high or prohibitive surgical risk.

Conditions

  • Diseases of Aortic Valve
  • Aortic Stenosis Disease

Interventions

DEVICE

Transcatheter aortic valve replacement

Transcatheter aortic valve replacement system

Sponsors & Collaborators

  • Genesis Medtech Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-14
Primary Completion
2024-07-03
Completion
2024-07-03

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05607667 on ClinicalTrials.gov